Works matching IS 14642662 AND DT 2000 AND VI 1 AND IP 3

Results: 86

Commentary on the summary of the French Guidelines for the treatment of HIV-infected adults with antiretroviral therapy.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 132, doi. 10.1046/j.1468-1293.2000.00017.x

By:

De Wit, S

Publication type:

Article

New French guidelines for antiretroviral treatment.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 133

By:

Delfraissy, J-F;
of, behalf;
of French researchers, a consensus panel composed;
advocates, community

Publication type:

Article

How generalizable are the results of large randomized controlled trials of antiretroviral therapy?

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 149, doi. 10.1046/j.1468-1293.2000.00019.x

By:

Moore, Daj;
Goodall, Rl;
Ives, Nj;
Hooker, M;
Gazzard, Bg;
Easterbrook, Pj

Publication type:

Article

A simple, once-daily dosing regimen for treating HIV-1 infection in intravenous drug users.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 162, doi. 10.1046/j.1468-1293.2000.00020.x

By:

Staszewski, S;
Haberl, A;
Carlebach, A;
Rottmann, C;
Miller, V;
Gute, P

Publication type:

Article

A case of lipodystrophy after the initiation of zidovudine, lamivudine and efavirenz in an asymptomatic HIV-1-infected patient.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 164, doi. 10.1046/j.1468-1293.2000.00021.x

By:

Rickerts, V;
Bickel, M;
Tews, J;
Jacobi, V;
Staszewski, S

Publication type:

Article

Disseminated infection due to Encephalitozoon cuniculi in a patient with AIDS: case report and review.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 155, doi. 10.1046/j.1468-1293.2000.00022.x

By:

Fournier, S;
Liguory, O;
Sarfati, C;
David-Ouaknine, F;
Derouin, F;
Decazes, Jm;
Molina, Jm

Publication type:

Article

Management of HIV and pregnancy in England's North Thames Region 1999: a survey of practice in 21 hospitals.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 143, doi. 10.1046/j.1468-1293.2000.00023.x

By:

Brook, Mg;
Taylor, Gp;
Dale, A;
Lyall, Egh;
Tomlinson, D

Publication type:

Article

O1 Compartmentalization of resistance mutations in HIV-1 between the lung and peripheral blood.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 166, doi. 10.1046/j.1468-1293.2000.00024-1.x

By:

White, N. C.;
Israel-Biet, D.;
Coker, R.;
Mitchell, D.;
Clarke, J. R.;
Weber, J. N.

Publication type:

Article

010 Quadruple HAART in primary infection: results from QUEST.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 168

By:

Lampe, F;
Phillips, An;
Kinloch, S;
Johnson, M;
Goh, L;
Hawkins, D;
Gazzard, B;
Fisher, M;
Freedman, A;
Group, Study

Publication type:

Article

011 The viral response to HAART over the first 16 weeks of therapy according to the pre-HAART and the 4–8-week viral load.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 169, doi. 10.1046/j.1468-1293.2000.00024-21.x

By:

Lepri, A Cozzi;
Miller, V;
Phillips, An;
Rabenau, H;
Sabin, C;
Staszewski, S

Publication type:

Article

012 AIDS-related lymphoma in the era of HAART.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 169, doi. 10.1046/j.1468-1293.2000.00024-23.x

By:

Matthews, G;
Bower, M;
Mandalia, S;
Powles, T;
Nelson, M;
Gazzard, B

Publication type:

Article

013 Normalization of intestinal permeability following antiretroviral therapy in HIV+ patients with diarrhoea.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 169, doi. 10.1046/j.1468-1293.2000.00024-25.x

By:

Miao, Ym;
Bjarnason, I.;
Crane, R;
Hayes, P;
Gazzard, B

Publication type:

Article

014 Does TB treatment alter virological and immunological response to HAART?

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 170, doi. 10.1046/j.1468-1293.2000.00024-27.x

By:

Dean, Gl;
Edwards, Sg;
Navaratne, L;
Matthews, G;
Fox, Ef;
Wood, Cg;
Fisher, M;
Churchill, Dr;
Taylor, Gp;
de Ruiter, A;
Taylor, C;
Pozniak, A

Publication type:

Article

015 Rapid onset lipodystrophy syndrome (LD) in three patients with prior severe nucleoside toxicity.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 170, doi. 10.1046/j.1468-1293.2000.00024-29.x

By:

de Burgh Thomas, A;
Creighton, S;
Edwards, Sg;
Taylor, C

Publication type:

Article

016 Type III hyperlipidaemia, related to PI treatment, is not caused by homozygosity for apoE2.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 170, doi. 10.1046/j.1468-1293.2000.00024-31.x

By:

Jaleel, H;
Shahmanesh, M;
DeSilva, Y;
Ross, Jdc;
Caslake, M;
Cramb, R

Publication type:

Article

017 A prospective study of lipid metabolism in HIV-1-seropositive patients treated with HAART.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 171, doi. 10.1046/j.1468-1293.2000.00024-33.x

By:

Morlese, J;
Ware, L;
Kruger, M;
Pozniak, A;
Jackson, A;
Wooton, S;
Gazzard, B

Publication type:

Article

O18 A dichotomy in CD4 T-cell responses specific to HIV antigens.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 171, doi. 10.1046/j.1468-1293.2000.00024-35.x

By:

Gotch, Fm;
Imami, N;
Gill, J;
Westby, M;
Wilson, Jdk

Publication type:

Article

O19 CD4+ T–cell responses in early HIV infection.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 171, doi. 10.1046/j.1468-1293.2000.00024-37.x

By:

Gloster, Se;
Harrop, R;
Newton, Pj;
Cornforth, Dm;
Balfe, P;
Williams, Ig;
Borrow, P

Publication type:

Article

O2 Comparison of viral drug resistance, adherence and PK indices in patients on successful and failing PI-based regimens.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 166, doi. 10.1046/j.1468-1293.2000.00024-3.x

By:

Walsh, Jc;
Brown, S;
Gazzard, B

Publication type:

Article

020 Antibody responses to HIV Gag and Env following highly active antiretroviral therapy (HAART).

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 172, doi. 10.1046/j.1468-1293.2000.00024-39.x

By:

Deayton, J;
Cope, Av;
Sabin, C;
Johnson, M;
Griffiths, Pd;
Emery, Vc

Publication type:

Article

021 Assessment of thymic activity by positron emission tomography in HIV patients on HAART.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 172, doi. 10.1046/j.1468-1293.2000.00024-41.x

By:

Worrell, S;
Hardy, G;
Hayes, P;
Aspinal, R;
Barnett, C;
Dutton, J;
Gotch, Fm;
Gazzard, B

Publication type:

Article

022 A heterosexual outbreak in Doncaster involving subtype B of HIV-1: molecular epidemiology as a supplement to contact tracing.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 172, doi. 10.1046/j.1468-1293.2000.00024-43.x

By:

Hayman, A;
Moss, T;
Arnold, C;
Naylor-Adamson, l;
Hawkswell, J;
Allen, K;
Radford, J;
Nguyen-Van-Tam, J;
Balfe, P

Publication type:

Article

023 Undiagnosed symptomatic acute HIV infections: a 12-month retrospective analysis of cases in South London.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 173, doi. 10.1046/j.1468-1293.2000.00024-45.x

By:

Melzer, M;
Brown, M;
O'Shea, S;
Mullen, J;
Parry, J;
Chrystie, I;
Banatvala, J

Publication type:

Article

024 Mortality in the HAART era.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 173, doi. 10.1046/j.1468-1293.2000.00024-47.x

By:

Sullivan, Ak;
Mazhude, C;
Nelson, M;
Fisher, M;
Chard, S;
Gazzard, B

Publication type:

Article

O3 Which are the most clinically useful questions in assessing adherence (AD)? A prospective comparative study.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 166, doi. 10.1046/j.1468-1293.2000.00024-5.x

By:

Walsh, Jc;
Gazzard, B

Publication type:

Article

O4 A novel point mutation assay for the detection of resistance to non-nucleoside reverse transcriptase inhibitors.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 167, doi. 10.1046/j.1468-1293.2000.00024-7.x

By:

Frater, A. J.;
Braganza, R.;
Clarke, J. R.;
Weber, J. N.;
McClure, M. O.

Publication type:

Article

O5 Genotypic drug-resistance testing in early HIV infection.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 167, doi. 10.1046/j.1468-1293.2000.00024-9.x

By:

Dean, Gl;
Cane, P;
Ratcliffe, D;
Workman, J;
Pillay, D;
Williams, Di;
Churchill, Dr;
Fisher, M

Publication type:

Article

O6 Genotypic resistance mutations and virological response to combination therapy in a clinical cohort.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 167, doi. 10.1046/j.1468-1293.2000.00024-11.x

By:

Quigg, M;
Harris, D;
Precious, H;
Clutterbuck, D;
Nicoll, S;
Burns, S;
McMillan, A;
Leen, C;
Brown, Aj Leigh

Publication type:

Article

O7 Structural solution of the HIV-1 packaging signal and use of RNA transcripts containing the signal as potential antiviral molecules.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 167, doi. 10.1046/j.1468-1293.2000.00024-13.x

By:

Lever, Aml;
Dorman, N;
Chadwick, D;
Hassard, S;
Zeffman, A;
Varani, G

Publication type:

Article

O8 HIV post-exposure prophylaxis (PEP): a retrospective review.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 168, doi. 10.1046/j.1468-1293.2000.00024-15.x

By:

Benn, P;
Mercey, D;
Williams, Ig

Publication type:

Article

09 One-year UK experience of nelfinavir in paediatric HIV-1.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 168, doi. 10.1046/j.1468-1293.2000.00024-17.x

By:

Mitchla, Z.;
Sharland, M.;
Delmas, N.;
Gibb, D.;
Tudor-Williams, G.;
Ball, C.;
Dumont, G.;
Klein, N.

Publication type:

Article

P1 Assessing the role of treatment adherence in a clinical setting.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 173, doi. 10.1046/j.1468-1293.2000.00024-49.x

By:

Jones, T;
Pillay, D;
Sabin, C;
Back, D;
Wilkins, E;
Lloyd, J;
Verbiest, W

Publication type:

Article

P10 The relationships between ethnicity, gender, risk factor and viral load (VL) in HIV-1 antiretroviral naive patients.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 176, doi. 10.1046/j.1468-1293.2000.00024-67.x

By:

Saul, J;
Kulasegaram, R;
Sabin, C;
Erwin, J;
Peters, B

Publication type:

Article

P11 Access to HIV medical services by HIV-positive black Africans in London.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 176, doi. 10.1046/j.1468-1293.2000.00024-69.x

By:

Erwin, J;
Gray, K;
Saul, J;
Peters, B

Publication type:

Article

P12 Uptake of antiretroviral therapy by African patients in a District General Hospital.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 176, doi. 10.1046/j.1468-1293.2000.00024-71.x

By:

Rodgers, M;
Newell, A

Publication type:

Article

P13 Assessing health-related quality-of-life in individuals with HIV/AIDS in the era of HAART.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 177, doi. 10.1046/j.1468-1293.2000.00024-73.x

By:

Miners, A;
Sabin, C;
Youle, M;
Mocroft, A;
Dykhoff, A;
Drinkwater, A;
Johnson, M;
Consortium, The Hiv Health Economics

Publication type:

Article

P14 A preliminary cost analysis of management options for individuals with prior history of CMV disease.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 177, doi. 10.1046/j.1468-1293.2000.00024-73.x

By:

Miners, A;
Edmunds, Wj;
Sabin, C;
Mandalia, S;
Youle, M;
Pillay, D;
Beck, Ej;
of, behalf;
Collaboration, the Npms-Hhc

Publication type:

Article

P15 Survival of patients with AIDS 1983–99.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 177, doi. 10.1046/j.1468-1293.2000.00024-77.x

By:

Chambers, E;
Brettle, R;
Wilson, A

Publication type:

Article

P16 Dual nucleoside therapy in the era of HAART.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 177, doi. 10.1046/j.1468-1293.2000.00024-79.x

By:

Mazhude, C;
Randerson, S;
Moriaty, S;
Churchill, Dr;
Fisher, M

Publication type:

Article

P17 Response of individuals with high viral load to non-nucleoside reverse transcriptase inhibitors.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 178, doi. 10.1046/j.1468-1293.2000.00024-81.x

By:

Nelson, M;
Shaw, A;
Baker, R;
Bower, M;
Fisher, M;
Gazzard, B

Publication type:

Article

P18 Comparison of combination antiretroviral chemotherapy in patients with low initial CD4 counts.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 178, doi. 10.1046/j.1468-1293.2000.00024-83.x

By:

Baker, R;
Gazzard, B;
Nelson, M

Publication type:

Article

P19 Response to second-line protease-inhibitor (PI) regimens: results from the EuroSIDA study.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 178, doi. 10.1046/j.1468-1293.2000.00024-85.x

By:

Mocroft, A;
Phillips, An;
Miller, V;
Gatell, J;
van Lunzen, J;
Lazzarin, A;
on, Jd Lundgren;
of, behalf;
Group, the EuroSida Study

Publication type:

Article

P2 DAART –- a 1-year review.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 173, doi. 10.1046/j.1468-1293.2000.00024-51.x

By:

Clarke, S;
Harrington, P;
Forkin, C;
Curran, S;
Keenan, E;
Mulcahy, F

Publication type:

Article

P20 Triple protease inhibitor combinations in patients with multidrug resistant HIV infection.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 179, doi. 10.1046/j.1468-1293.2000.00024-87.x

By:

Dragovic, B;
Moyle, G;
Youle, M;
Smith, Na

Publication type:

Article

P21 Prevalence of antiretroviral resistance mutations in treatment-naive HIV-1-infected patients in South London.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 179, doi. 10.1046/j.1468-1293.2000.00024-89.x

By:

Geretti, Am;
Smith, M;
Donati, M;
Easterbrook, P;
Zuckerman, M

Publication type:

Article

P22 AZT genotypic resistance in patients not exposed to AZT.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 179, doi. 10.1046/j.1468-1293.2000.00024-91.x

By:

Pozniak, A;
Gilleece, Y;
Nelson, M;
Hertogs, K;
Gazzard, B

Publication type:

Article

P23 Resistance testing by population sequencing is not reproducible for mixed populations.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 180, doi. 10.1046/j.1468-1293.2000.00024-93.x

By:

Frater, Aj;
Chaput, Cc;
Weber, Jn;
McClure, Mo

Publication type:

Article

P24 HIV resistance testing on archived samples aids current therapeutic decisions.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 180, doi. 10.1046/j.1468-1293.2000.00024-95.x

By:

Dean, Gl;
Fisher, M;
Loveday, C

Publication type:

Article

P25 The relationship between ARV drug levels, drug resistance, adherence and treatment failure in a routine clinical setting.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 180, doi. 10.1046/j.1468-1293.2000.00024-97.x

By:

Lloyd, J;
Sabin, C;
Pillay, D;
Jones, T;
Hoggard, P;
Wilkins, E;
Verbiest, W;
Hertogs, K

Publication type:

Article

P26 The feasibility of therapeutic drug monitoring (TDM) for HIV protease inhibitors (PIs).

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 180, doi. 10.1046/j.1468-1293.2000.00024-99.x

By:

Lloyd, J;
Maher, B;
Khoo, S;
Gibbons, S;
Back, D

Publication type:

Article